5.24
0.01 (0.20%)
| Penutupan Terdahulu | 5.22 |
| Buka | 5.42 |
| Jumlah Dagangan | 1,216 |
| Purata Dagangan (3B) | 8,793 |
| Modal Pasaran | 22,728,904 |
| Harga / Jualan (P/S) | 0.470 |
| Harga / Buku (P/B) | 3.00 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 25 Apr 2025 |
| Margin Keuntungan | -80.28% |
| Margin Operasi (TTM) | -202.50% |
| EPS Cair (TTM) | -9.82 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -34.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 242.97% |
| Nisbah Semasa (MRQ) | 0.460 |
| Aliran Tunai Operasi (OCF TTM) | -397.75 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -622.99 M |
| Pulangan Atas Aset (ROA TTM) | -5.20% |
| Pulangan Atas Ekuiti (ROE TTM) | -38.76% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Care Facilities (US) | Bercampur | Menurun |
| Medical Care Facilities (Global) | Bercampur | Bercampur | |
| Stok | Concord Medical Services Holdin | - | - |
AISkor Stockmoo
| Konsensus Penganalisis | 0.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | 3.5 |
| Osilator Teknikal | 2.0 |
| Purata | 0.88 |
|
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions. |
|
| Sektor | Healthcare |
| Industri | Medical Care Facilities |
| % Dimiliki oleh Orang Dalam | 18.00% |
| % Dimiliki oleh Institusi | 0.02% |
Tiada data dalam julat masa ini.
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 14 Jul 2025 | Pengumuman | Concord Healthcare Announces Completion of China's First Proton Therapy for Choroidal Malignant Melanoma |
| Purata Hasil Dividen 5T | 0.00% |
| Tarikh EX | Tarikh Pengumuman | Tarikh Pembayaran | Perincian |
|---|---|---|---|
| 23 Dec 2015 | - | 29 Jan 2016 | 0.98 Tunai |
| 05 Aug 2014 | - | 26 Sep 2014 | 0.89 Tunai |
| 16 Jan 2014 | - | 30 Jan 2014 | 0.71 Tunai |
| 29 Aug 2011 | - | 30 Sep 2011 | 0.17 Tunai |
| 29 Aug 2011 | - | 30 Sep 2011 | 0.18 Tunai |
Hasil Dividen Tahunan
| Tahun | Dividen Tahunan ($) | Kekerapan/Tahun | Hasil % |
|---|---|---|---|
| 2016 | 0.980 | 1 | 2.13 |
| 2014 | 1.60 | 2 | 2.50 |
| 2011 | 0.350 | 2 | 1.23 |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |